AIZ
78
2
PSA
58
5
XRX
34
-3
DTE
38
-4
SCHW
65
-2
NWSA
71
-2
FTI
78
-3
SIG
47
-2
CVX
38
6
EQR
60
6
HCP
70
-4
DOV
73
4
EW
32
3
PWR
71
-3
NOV
58
-2
BA
45
-3
KEY
46
-2
CNP
50
-2
UNH
63
-2
BAX
27
-2
AIZ
78
2
PSA
58
5
XRX
34
-3
DTE
38
-4
SCHW
65
-2
NWSA
71
-2
FTI
78
-3
SIG
47
-2
CVX
38
6
EQR
60
6
HCP
70
-4
DOV
73
4
EW
32
3
PWR
71
-3
NOV
58
-2
BA
45
-3
KEY
46
-2
CNP
50
-2
UNH
63
-2
BAX
27
-2
Financhill
Back

Columbia Research Enhanced Value ETF Vs. Neurogene Industry Stock Comparison

Buy
80

REVS
Columbia Research Enhanced Value ETF

Last Price:
26.38
Seasonality Move:
1.87%
Sell
5

NGNE
Neurogene

Last Price:
39.91
Seasonality Move:
50.43%
Buy
80
Columbia Research Enhanced Value ETF (REVS) is a Buy

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $26.38. The Score for REVS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • REVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $26.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 64.7 Buy
Chaikin Money Flow: -6572 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.47 - 26.17) Buy
Bollinger Bands (100): (23.81 - 25.61) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.14 Buy
20-day SMA: 25.84 Buy
50-day SMA: 25.42 Buy
200-day SMA: 23.88 Buy
8-day EMA: 26.18 Buy
20-day EMA: 25.9 Buy
50-day EMA: 25.45 Buy
200-day EMA: 23.97 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):